Skip to main content
. 2011 Nov 16;2012:204593. doi: 10.1155/2012/204593

Table 1.

Summary of FoxC2 expression and prognosis in human cancer.

Tumor type Number FoxC2 expression Prognosis
Melanoma [15] Vascular endothelial cells Not evaluated
Breast, colon [15] Adenocarcinoma Not evaluated
Esophageal [39] 70 Cytoplasm of cancer cells 5-year survival: 70% FoxC2 (low); 30% FoxC2 (high)
Breast [40] 18 Highly aggressive basal-like tumors Not evaluated
Breast [41] CD44high/CD24lowcells Not evaluated